Belimumab for systemic lupus erythematosus.

  title={Belimumab for systemic lupus erythematosus.},
  author={Bevra Hannahs Hahn},
  journal={The New England journal of medicine},
  volume={368 16},
n engl j med 368;16 april 18, 2013 1528 This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major clinical studies, the clinical use of this therapy, and potential adverse effects are reviewed. Relevant formal guidelines, if they exist, are presented. The article ends with the author’s clinical recommendations. Belimumab for Systemic Lupus… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 87 times over the past 90 days. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.


Publications citing this paper.
Showing 1-10 of 37 extracted citations


Publications referenced by this paper.
Showing 1-10 of 37 references

Clinical measures, metrics, and indices

  • Z Touma, DD Gladman, MB. Urowitz
  • 2013

The pathogenesis of SLE

  • BH Hahn
  • 2013

Similar Papers

Loading similar papers…